Study ID |
Country |
Evaluation type |
Analysis type |
An 2010 |
USA |
Observational study‐based |
Cost‐effectiveness |
Barnett 2013 |
USA |
Model‐based |
Cost‐effectiveness and cost‐utility |
Bauld 2011 |
UK |
Model‐based |
Cost‐effectiveness and cost‐utility |
Begh 2011 |
UK |
Trial‐based |
Cost‐utility |
Berndt 2016 |
Netherlands |
Trial‐based |
Cost‐effectiveness and cost‐utility |
Boyd 2009 |
USA |
Model‐based |
Cost‐effectiveness |
Calhoun 2016 |
USA |
Trial‐based |
Cost‐effectiveness and cost‐utility |
Cromwell 2001 |
USA |
Model‐based |
Cost‐effectiveness and cost‐utility |
Dino 2008 |
USA |
Model‐based |
Cost‐effectiveness |
Feenstra 2005 |
Netherlands |
Model‐based |
Cost‐effectiveness and cost‐utility |
Gilbert 2017 |
UK |
Trial‐based |
Cost‐effectiveness and cost‐utility |
Healey 2019 |
UK |
Model‐based |
Cost‐effectiveness and cost‐utility |
Javitz 2011 |
USA |
Trial and model‐based |
Cost‐effectiveness and cost‐utility |
Lal 2014 |
Australia |
Model‐based |
Cost‐effectiveness |
McGhan 1996 |
USA |
Model‐based |
Cost‐effectiveness |
Mudde 1996 |
Netherlands |
Observational study‐based |
Cost‐effectiveness |
Nohlert 2013 |
Sweden |
Trial and model‐based |
Cost‐effectiveness and cost‐utility |
Popp 2018 |
USA |
Trial and model‐based |
Cost‐effectiveness and cost‐utility |
Ruger 2008 |
USA |
Trial‐based |
Cost‐effectiveness and cost‐utility |
Shearer 2006 |
Australia |
Model‐based |
Cost‐effectiveness |
Smit 2013 |
Netherlands |
Trial‐based |
Cost‐effectiveness and cost‐utility |
Tosanguan 2016 |
Thailand |
Model‐based |
Cost‐utility |
Wu 2018 |
UK |
Trial and model‐based |
Cost‐effectiveness and cost‐utility |